Mutation of prps1 gene causing cmtx5 disease and the use thereof
AssigneeSungkyunkwan Unviersity Foundation for Corporate Collaboration
InventorsJong Won Kim, Hee Jin Kim
Life of this patent
Estimating the term…
Loading patent…
AssigneeSungkyunkwan Unviersity Foundation for Corporate Collaboration
InventorsJong Won Kim, Hee Jin Kim
Estimating the term…
Disclosed is a gene mutation associated with peripheral neuropathy associated with sensorineural hearing loss and optic neuropathy. More specifically, disclosed are: a polynucleotide comprising a mutation associated with peripheral neuropathy associated with sensorineural hearing loss and optic neuropathy, or a complementary polynucleotide thereof; a polynucleotide which hybridizes with said polynucleotide; a polypeptide which is encoded by said polynucleotide; an antibody which binds to said polypeptide; and a microarray chip and a kit, which comprise said polynucleotide. Also disclosed are a method for diagnosing a syndrome of peripheral neuropathy associated with sensorineural hearing loss and optic neuropathy, a method for detecting the mutation, and a method for screening drugs for treating these diseases.
A mutated PRPS1 (phosphoribosyl pyrophosphate synthetase 1) gene having a base sequence of SEQ ID NO:
A mutated PRPS1 protein having a decreased enzymatic activity, which is represented by an amino acid sequence of SEQ ID NO:
A polynucleotide for diagnosing peripheral neuropathy associated with sensorineural hearing loss and optic neuropathy, the polynucleotide comprising either a polynucleotide, which comprises a mutated base (344T→C) in a mutated gene of SEQ ID NO:
A method for peripheral neuropathy associated with sensorineural hearing loss and optic neuropathy, the method comprising the steps of:
Dependencies are inferred from the claim text.